Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Lucid Diagnostics Inc. Common Stock
LUCD | US
1.00
USD-0.03
-2.43%
LUCD | US
About Lucid Diagnostics Inc. Common Stock
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
03/06/2026
Close
1.00
Open
1.03
High
1.05
Low
1.00
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease who are at risk of developing esophageal precancer and cancer primarily highly lethal esophageal adenocarcinoma (EAC). It offers EsoCheck a cell collection device to prevent EAC deaths; and EsoGuard an Esophageal DNA Test. The company was incorporated in 2018 and is based in New York New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
View LessLUCD | US
Risk
47.1
Sharpe
-0.39
Luna's Score
39/100
Recommendation
Sell
Luna says (LUCD | US)
What's Working
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
62.6%1 month
47.1%3 months
62.4%6 months
60.3%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.16
Debt to equity
0.89
Debt to assets
0.42
Ent. to EBITDA
-0.67
Ent. to rev.
22.78
PEG
-
Other Fundamentals
EBITDA
-42.58M
MarketCap
49.59M
MarketCap(USD)
49.59M
Div. yield
-
Op. margin
-1.15K
Erngs. growth
-
Rev. growth
513.80
Ret. on equity
-300.52
Short ratio
5.07
Short perc.
5.63
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.22
Range1M
0.23
Range3M
0.59
Volumes: Market Activity
Rel. volume
0.86
Price X volume
821.30K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.67 | - | Cheaper |
| Ent. to Revenue | 22.78 | - | Expensive |
| PE Ratio | - | 30.41 | - |
| Price to Book | 2.16 | 6.21 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 62.37 | - | Par |
| Debt to Equity | 0.89 | -145.53 | Expensive |
| Debt to Assets | 0.42 | 0.35 | Par |
| Market Cap | 49.59M | - | Emerging |
